Exxon Mobil Corporation (XOM): what the price requires

At today's price, Exxon Mobil Corporation (XOM) is priced for +3.2% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/XOM

Headline

FieldValue
TickerXOM
CompanyExxon Mobil Corporation
Current price$144.88/sh
CompositionUnited States 42% / Non-U.S. 58%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed5.6%
Operating margin today12.0%
Margin compression implied-6.4pp
Implied growth3.2%
Multiple paid15x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.7% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.1pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.16σ
cohort percentile (of 45 peers)44
implied end-window share1%

Valuation X-Ray

Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.14x4expensive
Earnings2.67x2expensive
Relative1.88x3expensive
Growth2.56x4expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.

Per-Model Detail (n=13)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$43.613.32xyesFCF base $18.8B, growth -4% (input: historical growth), terminal g 0.5%, WACC 9.1%, 5yr projection
DCF Exit MultipleGrowth$118.691.22xyesExit EV/EBITDA: 17.7x / 22.7x / 27.7x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$77.001.88xyesP/E 14.22x (blended: static sector reference 10x + trailing (TTM) 24x), scenarios: 10.7x / 14.2x / 17.1x (bear / base = reference held flat / bull), EV/EBITDA 11.02x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$22.936.32xyesStage 1: -21% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$65.132.22xyesBV/sh $60.54, ROE (TTM) 10.0%, ke 9.3%
Two-Stage Excess ReturnAsset$67.492.15xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$80.181.81xyesRev $334.2B, growth -4% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.8x / 2.2x (bear / base = today's held flat / bull, cap 6x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset$67.912.13xyesBV $60.54 + 5yr PV of (ROE (TTM) 10.0% − Kₑ 9.3%) × BV; BV grows 6.5%/yr
Graham NumberAsset$89.951.61xyes√(22.5 × EPS $5.94 × BVPS $60.54) — Graham's conservative floor
EV/EBITDA RelativeRelative$37.193.90xyesEBITDA $27.06B × sector EV/EBITDA 6.0x
FCF YieldEarnings$46.903.09xyesFCF $18792.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$4.9829.09xyesEPS $5.94 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$95.451.52xyesRevenue $334.25B × sector P/S 1.2x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$64.222.26xyesEPS $5.94 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$12.3b
Net debt / NOPAT (after-tax)0.48x
Net debt / operating income (pre-tax)0.31x
Interest coverage54.7x
Share count CAGR (buyback)-0.4%
Burning cashno

Bullet Takeaways

Bull Case

The clearest argument for ExxonMobil is what it does with the cash, because the production and the balance sheet are the means and the distribution is the end. In 2025 the company returned a record $37.2 billion to shareholders, $17.2 billion in dividends and $20 billion in buybacks, and committed to holding the $20 billion annual repurchase pace through 2026. The 10-K codifies the buyback as a "share repurchase program with a $20 billion repurchase pace per year through 2026, assuming reasonable market conditions". A 4% dividend raise extended the streak to 43 consecutive years, which for a commodity business is the real signal: it tells you management has built a cost structure that funds the payout through the trough of the cycle, not just the peak.

The distribution is only durable because the upstream is genuinely advantaged. Permian output hit a record 1.8 million oil-equivalent barrels a day in the fourth quarter of 2025, Guyana topped 900,000 gross barrels a day with the Yellowtail project starting up four months ahead of schedule, and full-year production reached a record 4.7 million oil-equivalent barrels a day. The 10-K frames the upstream as a portfolio that lets the company "be selective in our investments, maximizing shareholder value", and that selectivity is the moat: low cost-of-supply barrels keep generating cash at oil prices that strand higher-cost producers. The advantaged-volume growth showed up in the segment results, where new projects added earnings even as commodity margins moved against parts of the business.

The balance sheet is what lets the company act counter-cyclically. Net debt sits near $12.3 billion against trailing operating income above $40 billion, leverage of roughly 0.3 times that income, and interest coverage near 58 times. The 10-K is explicit about why this matters, noting the "capital-intensive nature of the industry and very long lead times associated with many of our projects" make a strong financial position essential. When peers retrench in a downturn, Exxon can keep buying back stock at a $20 billion pace and keep investing in Guyana and the Permian, which is precisely how an integrated major compounds through a cycle rather than just riding it.

Bear Case

An integrated oil major's biggest hazard is mistaking peak earnings for sustainable earnings, and the segment results make the risk concrete. Chemical Products spent 2025 at what the 10-K calls "bottom-of-cycle market conditions", where oversupply cut earnings by $1.8 billion, while Energy Products did the opposite, with margins adding $1.8 billion "mainly driven by robust" demand. The two roughly offset, which is the point: consolidated earnings at any moment are a blend of segments at different points in their own cycles, and the current mix flattered refining and punished chemicals. A price that capitalizes the blend as if it were steady-state is paying for the refining strength to hold and the chemicals weakness to reverse on schedule, neither of which the company controls.

The demand backdrop is the longer-dated bear. The 10-K names the structural pressures directly, citing "demand for alternative-fueled or electric transportation or alternatives to plastic products" and broad changes in income levels as forces that shape the business, with a separate climate and energy-transition discussion behind it. None of that is imminent enough to break the cash flow, but it caps the terminal value the market should be willing to assign to a hydrocarbon franchise, and it raises the cost of capital the market demands for very long-lead projects whose payback runs decades. Crude and gas prices are the near-term swing factor, and they are set by global supply and demand the company cannot steer.

Then there is the price relative to the methods. Reading across the valuation families, no family reaches today's price: the asset-based lens lands at roughly half, the earnings-power and forward-growth methods near 40% of the price, and even the peer-multiple lens sits below it. The inversion says the price embeds only about 1.4% annual operating-income growth for five years, which is within what the company has delivered, so the stretch is not the rate but the duration, the assumption that a cyclical earnings base persists at this level for the full horizon. That is the bear's arithmetic: the price is not betting on a boom, it is betting that the current, commodity-dependent earnings power does not fade, and in a business defined by the cycle that is itself a meaningful wager.

Valuation

At today's price the market pays about 14 times company-wide operating income, which inverts to roughly 1.4% annual operating-income growth sustained for five years. Measured against ExxonMobil's own record, that near-term pace is within what it has recently delivered, so the demanding part of the assumption is its persistence rather than its rate. For a commodity business, that distinction is the whole valuation question: the rate is achievable in any single good year, but holding it across a full cycle means the trough years have to be shallow enough not to break the average.

The valuation families agree that the price runs ahead of the static evidence. The price sits at roughly twice where the asset-based methods land, about 2.5 times the earnings-power and forward-growth methods, and near 1.8 times the peer-multiple lens. No family reaches the price, which characterizes it as a bet beyond what any standard frame supports on the current numbers. For an integrated major that is not unusual; the methods anchor on trailing, cyclically blended earnings, and the price additionally credits the advantaged-barrel growth from Guyana and the Permian plus the company's record of converting that into distributions. The spread is the premium the market pays for that compounding, not a sign the methods are broken.

Solvency is the strongest single line in the file. Net debt of about $12.3 billion against operating income above $40 billion is leverage near a third of one year's operating profit, and interest coverage around 58 times means debt service is a rounding error against the cash flow. The 10-K ties that conservatism to the "capital-intensive nature of the industry and very long lead times" that make balance-sheet strength a competitive tool. The downside case is not insolvency; it is a sustained commodity downturn that compresses the earnings the price capitalizes, which the dividend record suggests management is structured to absorb while continuing to return cash.

Catalysts

The 2025 full-year results were the most recent marker and they came in ahead of expectations, with the upstream doing the heavy lifting. Production reached a record 4.7 million oil-equivalent barrels a day, the Permian set a fourth-quarter record at 1.8 million, and Guyana exceeded 900,000 gross barrels a day with the Yellowtail project starting up four months ahead of schedule. Project execution running ahead of plan is a direct catalyst for 2026 volumes, since it pulls forward the production the market is paying for.

Capital returns are the recurring catalyst. The company distributed a record $37.2 billion in 2025, comprising $17.2 billion in dividends and $20 billion in repurchases, raised the quarterly dividend by 4% for a 43rd straight year of growth, and reaffirmed the $20 billion annual buyback pace through 2026. With the share count already drifting lower, each quarter of buyback at that pace is a steady reduction in the base over which earnings and dividends are spread.

Sentiment has moved with the production story. Argus raised its price target to $169 citing Permian and Guyana growth powering 2026, and JPMorgan lifted its target to $170 with an overweight rating. The events most likely to move the thesis from here are the quarterly volume prints from Guyana and the Permian, any inflection in chemicals margins off the bottom of their cycle, and the path of crude and gas prices, which remain the dominant input to a business whose results the company itself ties to global supply and demand.

Peer Cohorts (Per Segment, With Filing Citations)

Upstream (reported)

Energy Products (reported)

Chemical Products (reported)

Specialty Products (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

ExxonMobil 2025 results, January 2026 · analyst notes via 24/7 Wall St., 2026

View the full interactive XOM report on boothcheck